The Journal of Dermatological Treatment
Overview
The Journal of Dermatological Treatment is a peer-reviewed medical journal that focuses on the diagnosis, treatment, and management of various dermatological conditions. It publishes high-quality research articles, clinical studies, and reviews, providing valuable insights into the latest advancements in dermatological treatment modalities, including pharmacological, surgical, and cosmetic interventions. This journal serves as a valuable resource for dermatologists, researchers, and healthcare professionals seeking evidence-based information to enhance patient care and outcomes in the field of
Details
Details
Abbr.
J Dermatolog Treat
Publisher
Informa Healthcare
Start
1989
End
Continuing
Frequency
Quarterly
p-ISSN
0954-6634
e-ISSN
1471-1753
Country
United Kingdom
Language
English
Specialty
Dermatology
Metrics
Metrics
h-index / Ranks: 5814
63
SJR / Ranks: 3827
997
CiteScore / Ranks: 5069
5.00
JIF / Ranks: 3624
2.9
Recent Articles
1.
Ke C, Huang Y, Chen C, Chen X, Ke Y
J Dermatolog Treat
. 2025 Mar;
36(1):2477257.
PMID: 40073869
Background: Melasma is a common pigmentary skin disorder. Q-switched Nd:YAG laser therapy is commonly used, but its efficacy is limited. PhotoAcoustic Technology Pulse (PTP) mode is a newer technology that...
2.
Yang H, Choi S, Jung J, Jo Y, Han H, Lee Y, et al.
J Dermatolog Treat
. 2025 Mar;
36(1):2469633.
PMID: 40068225
Purpose: This study aimed to investigate the effectiveness and safety of a new monopolar radiofrequency device equipped with a 5 cm tip, against fine wrinkles around the eyes and cheeks....
3.
Chovatiya R, Chang C, Aldredge L, Heath C, Acevedo M, Chu D, et al.
J Dermatolog Treat
. 2025 Mar;
36(1):2476576.
PMID: 40068222
Introduction: Seborrheic dermatitis (SD) affects a large, diverse population and is associated with significant morbidity/burden. Methods: The Harris Poll conducted online surveys to understand the perceptions, preferences, and experiences regarding...
4.
Su X, Ou Y, Ruan S, Lv X, Qin K, Mao J, et al.
J Dermatolog Treat
. 2025 Mar;
36(1):2474507.
PMID: 40051127
Background: Emerging research suggests that Janus kinase-signal transducer and activator of transcription (JAK-STAT) inhibitors may be associated with a higher risk of serious infection for patients with rheumatoid arthritis. However,...
5.
AlFada M, Alotaibi H, Alsharif S, Alani A, Andrade-Miranda A, Montesinos Guevara C, et al.
J Dermatolog Treat
. 2025 Feb;
36(1):2467751.
PMID: 40010698
Purpose: The Appraisal of Guidelines for Research and Evaluation II Instrument (AGREE II) was developed to enhance the methodological rigor of clinical practice guidelines (CPGs), aiming to generate trustworthy recommendations...
6.
Gupta A, Economopoulos V
J Dermatolog Treat
. 2025 Feb;
36(1):2471451.
PMID: 40009714
Background: Vitiligo is an autoimmune skin depigmentation disorder significantly impacting quality of life. This condition is difficult to treat, with high relapse rates. Additionally, vitiligo associates with other autoimmune conditions,...
7.
Tingting L, Zhang P, Yang L, Li R, Wang R
J Dermatolog Treat
. 2025 Feb;
36(1):2470379.
PMID: 39993425
Objective: This study aims to analyze the different therapeutic responses between topical antimicrobial-corticosteroid combination and topical corticosteroids alone on improving the skin microbiome and skin barrier of patients with atopic...
8.
Marquez-Grap G, Kranyak A, Brownstone N, Koo J
J Dermatolog Treat
. 2025 Feb;
36(1):2466635.
PMID: 39988333
One of the most well-known medications for treating delusional infestation (DI) is pimozide. Many patients may be reluctant to initiate treatment unless a medication has anti-pathogenic properties, as they feel...
9.
Evaluating the necessity of formal atopic dermatitis severity measurement tools in clinical practice
Buttar B, Yi R, Ruley A, Fleischer Jr A, Feldman S
J Dermatolog Treat
. 2025 Feb;
36(1):2469646.
PMID: 39987919
No abstract available.
10.
Zhang H, Zhou J, Tang K, Zhang X, Jin H
J Dermatolog Treat
. 2025 Feb;
36(1):2460582.
PMID: 39956544
Purpose: This review aims to outline the crucial role of IL-36 signaling in inflammatory skin diseases and summarize the therapeutic potential of spesolimab. Our goal is to provide insights into...